Price (delayed)
$0.911
Market cap
$39.76M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.53
Enterprise value
$35.38M
Millendo Therapeutics is a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct
There are no recent dividends present for TPST.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.